Source comparison
PT-141 vs Viagra: Head-to-Head Comparison
Before selecting between these compounds, understanding the categorical differences is essential. Not just efficacy percentages. Mechanism Melanocortin receptor agonist (MC3R/MC4R) in CNS PDE5 inhibitor in vascular smooth muscle PT-141 modulates desire central
This comparison does not assign a generated winner or score.
- Before selecting between these compounds, understanding the categorical differences is essential. Not just efficacy percentages.
- Mechanism
- Melanocortin receptor agonist (MC3R/MC4R) in CNS
- PDE5 inhibitor in vascular smooth muscle
- PT-141 modulates desire centrally; Viagra enhances blood flow peripherally
- Primary Indication
- Hypoactive sexual desire disorder (HSDD) in women
- Erectile dysfunction in men
- Different disorders. Not interchangeable diagnoses
- Administration Route
- Subcutaneous injection (abdomen or thigh)
- Oral tablet
- PT-141 requires injection comfort; Viagra is non-invasive
- Onset Time
- 45–90 minutes
- 30–60 minutes
- Viagra acts faster for on-demand use
- Duration
- 6–12 hours
- 4–6 hours
- PT-141 provides longer window
- Efficacy in Vascular ED
- Minimal. Does not address hemodynamics
- 60–85% depending on severity
- Viagra is first-line for vascular causes
- Efficacy in Desire Disorders
- Statistically significant in RECONNECT trials
- Ineffective. Does not cross blood-brain barrier
- PT-141 is the only FDA-approved option for HSDD
- Side Effects
- Nausea (40%), flushing (20%), transient hypertension
- Headache (16%), flushing (10%), nasal congestion (4%)
- PT-141's nausea incidence is significantly higher
- Contraindications
- Uncontrolled hypertension, cardiovascular disease
- Nitrate use, recent MI or stroke
- Cardiovascular screening required for both
- Off-Label Male Use
- Anecdotal. Limited trial data
- Widely used off-label for altitude sickness, Raynaud's
- PT-141 male data is emerging but not robust
- Professional Assessment
- Best for central desire deficits unresponsive to vascular interventions
- Best for vascular erectile dysfunction with intact arousal pathways
- Mechanism dictates patient fit. Select based on etiology, not preference
- The bottom row is critical. Selecting PT-141 for a patient with pure vascular ED is mechanistically inappropriate. Selecting Viagra for a patient with intact erectile function but absent desire is equally misguided.